Ph.D. Sir Marc Feldmann - 15 Dec 2023 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role
Director
Signature
/s/ Sir Marc Feldmann, Ph.D.
Issuer symbol
ATNF
Transactions as of
15 Dec 2023
Net transactions value
-$4,700
Form type
4
Filing time
18 Dec 2023, 16:15:24 UTC
Previous filing
08 Sep 2023
Next filing
28 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATNF Common Stock Sale $4,700 -25,000 -18% $0.1880 115,497 15 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective on December 15, 2023, Prof. Sir Marc Feldmann, the Co-Executive Chairman of the Issuer, sold 25,000 shares of common stock of the Issuer to Dr. James N. Woody, the Chief Executive Officer of the Issuer, in a private transaction, for $4,720 or $0.188 per share, the closing sales price of the Issuer's common stock on such effective date.